Current News‎ > ‎

WPC acquired by private-equity backed Intermedix

posted Apr 5, 2017, 4:51 AM by Lyle Beasley   [ updated Apr 5, 2017, 4:52 AM ]

Intermedix buys analytics venture WPC

Predictive data company spun out of Seattle-based conglomerate in 2014

AUTHORS Geert De Lombaerde

Health care IT company Intermedix has acquired fellow local venture WPC Healthcare to make its first move into the clinical analytics space.

The deal will more than double the Nashville analytics team of Intermedix, which 18 months ago moved its main office here and set up an innovation lab. WPC is home to about a dozen people — Intermedix employs about 70 people here and 2,500 globally — and led by CEO Ray Guzman, who has been named Intermedix’s senior vice president of strategy.

Terms of the company’s acquisition are not being disclosed.

“Data science and machine learning are the future of health care," said Joel Portice, CEO of Intermedix, which has as its main business revenue cycle management and practice management. “The addition of WPC to our suite of solutions is a testament to our company’s commitment to further our investment in health care data analytics in order to assist our customers in managing care and optimizing their revenue cycle.”

WPC’s data analytics products use machine learning to make predictions about health care conditions, giving providers an early heads up of the spread of outbreaks. 

The WPC team will relocate from Brentwood to Intermedix’s Fifth Third Center space in the next few weeks. The deal comes about a year and a half after Guzman led a buyout of WPC — backed by local investment firm West End Holdings and CapStar Bank — from Seattle-based Washington Publishing Co.

“As a team, we have been able to create significant innovation in the health care environment and have developed solutions over the years that have truly saved lives,” Guzman said in a statement. “By joining Intermedix, we now have the right partner to take our expertise to market and share our solutions on a much wider scale.”

Relatedly, Intermedix last week announced that Executive Vice President Kyle Wailes had been promoted to CFO.